Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy
Clinical trial NCT05440643 · COMPLETED
Trial details
- NCT number
- NCT05440643
- Sponsor
- ALK-Abelló A/S
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-07
- Primary completion
- 2026-03-10
- Enrollment
- 209
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.